Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

Chak Sing Lau; Yi Hsing Chen; Keith Lim; Marc de Longueville; Catherine Arendt; Kevin Winthrop

doi:10.1007/s10067-020-05356-1

Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

Chak Sing Lau^*, Yi Hsing Chen, Keith Lim, Marc de Longueville, Catherine Arendt, Kevin Winthrop

^*此作品的通信作者

醫學系內科學科

研究成果: Comment/debate

摘要

The original published version of the above article contained an error.

原文	English
頁（從 - 到）	3161
頁數	1
期刊	Clinical Rheumatology
卷	39
發行號	10
DOIs	https://doi.org/10.1007/s10067-020-05356-1
出版狀態	Published - 1 10月 2020

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1007/s10067-020-05356-1

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)」主題。共同形成了獨特的指紋。

引用此

Lau, C. S., Chen, Y. H., Lim, K., de Longueville, M., Arendt, C., & Winthrop, K. (2020). Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4). Clinical Rheumatology, 39(10), 3161. https://doi.org/10.1007/s10067-020-05356-1

@article{c01b81a8b5fb484499e0eb6df95e9480,

title = "Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)",

abstract = "The original published version of the above article contained an error.",

author = "Lau, {Chak Sing} and Chen, {Yi Hsing} and Keith Lim and {de Longueville}, Marc and Catherine Arendt and Kevin Winthrop",

note = "Publisher Copyright: {\textcopyright} 2020, International League of Associations for Rheumatology (ILAR).",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s10067-020-05356-1",

language = "English",

volume = "39",

pages = "3161",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "10",

}

Lau, CS, Chen, YH, Lim, K, de Longueville, M, Arendt, C & Winthrop, K 2020, 'Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)', Clinical Rheumatology, 卷 39, 編號 10, 頁 3161. https://doi.org/10.1007/s10067-020-05356-1

Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4). / Lau, Chak Sing; Chen, Yi Hsing; Lim, Keith 等.
於: Clinical Rheumatology, 卷 39, 編號 10, 01.10.2020, p. 3161.

研究成果: Comment/debate

TY - JOUR

T1 - Correction to

T2 - Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

AU - Lau, Chak Sing

AU - Chen, Yi Hsing

AU - Lim, Keith

AU - de Longueville, Marc

AU - Arendt, Catherine

AU - Winthrop, Kevin

PY - 2020/10/1

Y1 - 2020/10/1

N2 - The original published version of the above article contained an error.

AB - The original published version of the above article contained an error.

UR - http://www.scopus.com/inward/record.url?scp=85090115213&partnerID=8YFLogxK

U2 - 10.1007/s10067-020-05356-1

DO - 10.1007/s10067-020-05356-1

M3 - Comment/debate

C2 - 32876785

AN - SCOPUS:85090115213

SN - 0770-3198

VL - 39

SP - 3161

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 10

ER -

Lau CS, Chen YH, Lim K, de Longueville M, Arendt C, Winthrop K. Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4). Clinical Rheumatology. 2020 10月 1;39(10):3161. doi: 10.1007/s10067-020-05356-1